Similarly, we found that baseline IL-6 and leptin levels were higher in participants with glycemic progression at the 10-year follow-up and that leptin level was significantly associated with higher glucose level, insulin resistance, and dyslipidemia. This evidence concerns the gene LEP and metabolic syndrome.